{"id":"W2560342953","doi":"10.1186/s40425-016-0191-4","title":"31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Columbia College; University Health Network; Princess Margaret Cancer Centre; Université Laval","funders":"National Center for Advancing Translational Sciences; lékařská fakulta Univerzity Karlovy; Radboud Universitair Medisch Centrum; Université Paris Descartes; EMD Serono; Kindai University; Radboud Universiteit; Karolinska Institutet; Institut National de la Santé et de la Recherche Médicale; Université Pierre et Marie Curie; Dr. Ralph and Marian Falk Medical Research Trust; Sidra Medicine; Graduate School, University of Maryland; Pennsylvania Department of Health; University of Bern; Univerzita Karlova v Praze; National Cancer Institute; Alliance for Cancer Gene Therapy; National Institutes of Health; Keio University; National Science Foundation","keywords":"Durvalumab; Lung cancer; CD8; Immunotherapy; Cancer immunotherapy; Oncology; Medicine; Cancer research; Internal medicine; Cancer; Immunology; Immune system; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001332357,0.0003055217,0.0008152646,0.00009139876,0.0002514346,0.000025935,0.0002979424,0.0002348507,0.000104053],"category_scores_gemma":[0.00005684641,0.00017384,0.001404004,0.0002527239,0.0004404162,0.0002106553,0.00002466983,0.0002105586,8.294323e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003167039,"about_ca_system_score_gemma":0.0007428001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001047784,"about_ca_topic_score_gemma":0.0002438509,"domain_scores_codex":[0.9974928,0.0000542024,0.001240316,0.0002507025,0.0004879397,0.0004740272],"domain_scores_gemma":[0.996195,0.0003022224,0.002185477,0.0003030961,0.0009481469,0.00006601424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008109531,0.0002222386,0.01538448,0.0002307597,0.004113358,2.779453e-7,0.001911581,0.00001333277,0.6123388,0.00001144016,0.001340791,0.3563234],"study_design_scores_gemma":[0.05568094,0.003668515,0.2715201,0.01399419,0.001040834,0.00004988322,0.0012302,0.00008578471,0.4768506,0.0006809541,0.1743565,0.0008415534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.940114,0.05402671,0.0002006987,0.002759772,0.0009659839,0.001406286,0.0004424714,0.0000189902,0.00006514243],"genre_scores_gemma":[0.9526955,0.04260371,0.001090202,0.0006012314,0.0003540445,0.0001915423,0.000005342661,0.0001175432,0.002340913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3554818,"threshold_uncertainty_score":0.7088989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01752941661231215,"score_gpt":0.3185434224669422,"score_spread":0.30101400585463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}